Qlucore Bioinformatics Software Development
Qlucore is a leader in the development of bioinformatics software. Qlucore Omics Explorer is a next-generation data analysis software. It works for many different types of data, such as gene expression, DNA methylation and protein array data.
The data analysis software will support the unveiling of important new discoveries as it will allow the actual researchers – the people with the most biological insight – to study important data and to look for patterns and structures, without needing to be a statistics or computer expert. The data analysis software is very easy to use, and the user is always provided with instant feedback.
Next-generation data analysis software
Qlucore Omics Explorer is a next-generation data analysis software. It enables researchers to analyse and explore extremely large data sets (containing up to more than 100 million data samples) on a regular PC or Mac. The data analysis software takes full advantage of all annotations and other links that are connected with the data being studied, as well as a number of powerful statistical functions such as false discovery rates (FDR), f-tests, Anova and p-values.
All results are instantly visualised in any of the many plot types. Plot types such as heatmap and principal component analysis (PCA) are supported. The user can work with any number of synchronised plot types in order to analyse the data from several angles at the same time.
Gene expression analysis software
Although Qlucore Omics Explorer was initially used for gene expression analysis, the data analysis software enables the easy import of many types of data. The software is Affymetrix GeneChip-compatible. Expression values can be combined with annotations.
Qlucore Omics Explorer provides a wide range of methods to analyse gene expression data efficiently. Examples of functionality are variance filtering and Anova with instant visual feedback of the results, as well as heatmap (with hierarchical clustering), sample PCA, variable PCA, and scatter plots to support instant visual data investigation.
Protein analysis software
Qlucore Omics Explorer is also used for various types of protein array, antibody arrays and proteomics data. A wide range of tools for statistical analysis is available. Examples include t-tests and f-tests based on Anova. The statistical model works with eliminated factors and the user can compensate for unwanted disturbances with just a few mouse clicks.
Instant analysis of data
Qlucore Omics Explorer provides immediate response to all user action and allows instant analysis of data. The user can work with data sets with up to 1,000 samples and 100,000 variables (or opposite) on a regular PC or Mac and is still provided with instant response to all actions.
Analysis software for biologists
Qlucore Omics Explorer is the preferred analysis software for the biologist or scientist with a biological or medical background. Biologists will find the product very easy to use and will appreciate the ability to analyse data directly. In addition, the Qlucore software will allow them to combine their own biological knowledge with experiment data in order to test a variety of different ideas and communicate results easily.
With its rich functionality and flexibility Qlucore Omics Explorer is also a valuable data software tool for bioinformatics. By using a powerful statistical model, Qlucore Omics Explorer gives bioinformaticians an instant feeling for the data they are studying. Qlucore Omics Explorer also includes a unique export function where the user can export the exact state of the analysis. This allows for easy communication of results to key research partners, such as biologists and other team members, in a very efficient way.
Products and Services
Fujifilm Corporation and Merck, known as MSD outside the US and Canada, have announced that they have entered into a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a leading provider of contract manufacturing and development services for the biopharmaceutRead more
Q Chip and ARTES Biotechnology have announced that they have signed a collaborative agreement to explore the co-development of a new sustained release formulation of interferon alpha 2a for the treatment of chronic hepatitis B and C. The study is designed to evaluate Q Chips' Q-Sphera&Read more
ARTES Biotechnology has announced its collaboration with five other collaboration partners in a joint 28-month research programme that is granted by the national Deutsche Stiftung Umwelt within the ChemBioTec initiative. The Deutsche Bundesstiftung Umwelt DBU is one of Europe's largest foundationRead more
ARTES has announced that it has signed an exclusive marketing agreement with the Institute of Cell Biology of the National Academy of Science of Ukraine. The agreement is that the NAS technology based on the yeast organism Hansenula polymorpha is now exclusively marketed and licensed by ARTES BioRead more
ARTES Biotechnology has announced its collaboration with Henkel in a joint three-year research programme that is granted by the German national BMBF (German Ministery of Education and Research) within the CLIB2021 cluster (Wettbewerb Industrielle Biotechnologie 2021). The cooperation aims to advaRead more
ARTES Biotechnology, which specializes in recombinant protein production from yeast expression systems, and Rhein Minapharm Biogenetics, a subsidiary of Minapharm, jointly announced the start of a strategic collaboration to develop three therapeutic proteins. Financial details were not disclosed.Read more
ARTES Biotechnology GmbH expands technology platform Having achieved notable success with the Hansenula technology for years, the biotech company ARTES has now concluded an exclusive partnership with the internationally renowned Leibniz Institute of Plant Genetics and Crop PlantRead more
"We are looking forward to working with an international team“, says Dr Melanie Dröttboom, head of business development of Artes Biotechnology GmbH. Biotech company Artes, based near Düsseldorf, has been confirmed that it is developing an aptamer-based microarray forRead more
ACE Pharmaceuticals today announced that the first patient has entered the Phase III trial also known as the Levamisole trial. This trial was accepted by the EMEA by November 2006. The goal of this trial, which was accepted by the EMEA in November 2006, is to assess the efficacy and saRead more
ARTES announces the grant of the European patent on increasing recombinant protein secretion in yeast by co-expression of Calnexin, a protein responsible in intracellular quality control and sorting. In extensive studies, ARTES could show that overexpression of Calnexin results in signRead more
PROTEO Biotech AG and ARTES Biotechnology GmbH: Strategic Alliance for Marketing of Elafin in Asia, Africa and South America
Kiel - Erkrath, June 19, 2006. PROTEO Biotech AG, a wholly owned subsidiary of PROTEO Inc., USA, has signed a cooperation agreement with ARTES Biotechnology GmbH. The aim of the agreement is the marketing of Elafin, the lead product of PROTEO Biotech AG / PROTEO Inc., in India, Egypt and ArgentinRead more